Technology ❯ Biotechnology ❯ mRNA Technology ❯ Vaccine Development

Clinical Trials

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

The agency said Moderna’s study used a control that did not reflect the top standard of care, a rationale the company disputes.

HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial